These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 19085649)
21. Diagnosis and treatment of von Willebrand disease. Cox Gill J Hematol Oncol Clin North Am; 2004 Dec; 18(6):1277-99, viii. PubMed ID: 15511616 [TBL] [Abstract][Full Text] [Related]
22. Distinguishing between type 2B and pseudo-von Willebrand disease and its clinical importance. Enayat MS; Guilliatt AM; Lester W; Wilde JT; Williams MD; Hill FG Br J Haematol; 2006 Jun; 133(6):664-6. PubMed ID: 16704444 [TBL] [Abstract][Full Text] [Related]
23. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions. Jacquemin M Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355 [TBL] [Abstract][Full Text] [Related]
24. Genetic defects in von Willebrand disease type 3 in Indian and Greek patients. Gupta PK; Saxena R; Adamtziki E; Budde U; Oyen F; Obser T; Schneppenheim R Blood Cells Mol Dis; 2008; 41(2):219-22. PubMed ID: 18485763 [TBL] [Abstract][Full Text] [Related]
25. Using genetic diagnostics in hemophilia and von Willebrand disease. Swystun LL; James P Hematology Am Soc Hematol Educ Program; 2015; 2015():152-9. PubMed ID: 26637715 [TBL] [Abstract][Full Text] [Related]
26. Re-evaluation of three Israeli families initially diagnosed with type 1 von Willebrand disease in light of the ISTH update on von Willebrand factor pathophysiology and classification. Hashemi Soteh SM; Anson J; Inbal A; Peake IR; Goodeve AC Haemophilia; 2008 May; 14(3):621-4. PubMed ID: 18384353 [No Abstract] [Full Text] [Related]
27. Genetics of type 1 von Willebrand disease. Goodeve A Curr Opin Hematol; 2007 Sep; 14(5):444-9. PubMed ID: 17934350 [TBL] [Abstract][Full Text] [Related]
37. Diagnosis of von Willebrand disease in South Island, New Zealand. Rajagopal R; Smith MP Semin Thromb Hemost; 2011 Jul; 37(5):555-9. PubMed ID: 22102199 [TBL] [Abstract][Full Text] [Related]
38. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease. De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568 [TBL] [Abstract][Full Text] [Related]
39. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene. Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361 [TBL] [Abstract][Full Text] [Related]
40. Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology. Mazurier C; Goudemand J; Hilbert L; Caron C; Fressinaud E; Meyer D Best Pract Res Clin Haematol; 2001 Jun; 14(2):337-47. PubMed ID: 11686103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]